Type to search

FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue | Pharmtech Focus
FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia | Pharmtech Focus
Roche Receives FDA Approval for First Companion Diagnostic to Identify dMMR Solid Tumour Patients Eligible for Anti-PD-1 Immunotherapy | Pharmtech Focus